Towards a proposal for assessment of blinding success in clinical trials: Up-to-date review

Jafar Kolahi, Heejung Bang, Jongbae Park

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The CONSORT statement recommended that investigators should clearly report which key trial persons were blinded to treatment allocation and test for the success of blinding. Clinical researchers, however, more often than not overlook the assessment of the success of blinding. The severe under-reporting on the success of blinding may improve with awareness of existing quantitative methods. The two statistical methods, James' blinding index (BI) and Bang's BI, are currently available. Subjects could be asked to guess their treatment assignment, possibly with an option to express the degree of certainty. Assessments of blinding at various points may serve different purposes, i.e. to evaluate comparability between experimental versus control treatments before the trial by the third party; to examine further comparability and credibility of the control treatment and patients' expectation about treatment received in early stage of the trial, and to summarize the overall maintenance of the blinding success at the end of the trial. In this article, we review BIs and how to use these methods along with discussion of other issues in blinding assessment and reporting. We contend the two BIs that were independently developed but carry complementary properties would characterize blinding behaviours in clinical trials qualitatively as well as quantitatively, and may also shed some lights on the interpretation of the study findings. Finally we urge the Item 11b of the CONSORT statement to be revised to require the assessment/reporting of blinding success for all trials that adopt blinding schemes.

Original languageEnglish (US)
Pages (from-to)477-484
Number of pages8
JournalCommunity Dentistry and Oral Epidemiology
Volume37
Issue number6
DOIs
StatePublished - Dec 2009
Externally publishedYes

Fingerprint

Clinical Trials
Research Personnel
Therapeutics
Maintenance
Light

Keywords

  • Blinding index
  • Methods
  • Randomized controlled trials
  • Standards

ASJC Scopus subject areas

  • Dentistry(all)
  • Public Health, Environmental and Occupational Health

Cite this

Towards a proposal for assessment of blinding success in clinical trials : Up-to-date review. / Kolahi, Jafar; Bang, Heejung; Park, Jongbae.

In: Community Dentistry and Oral Epidemiology, Vol. 37, No. 6, 12.2009, p. 477-484.

Research output: Contribution to journalArticle

@article{c97957740ec84d46909c11a0b7567b56,
title = "Towards a proposal for assessment of blinding success in clinical trials: Up-to-date review",
abstract = "The CONSORT statement recommended that investigators should clearly report which key trial persons were blinded to treatment allocation and test for the success of blinding. Clinical researchers, however, more often than not overlook the assessment of the success of blinding. The severe under-reporting on the success of blinding may improve with awareness of existing quantitative methods. The two statistical methods, James' blinding index (BI) and Bang's BI, are currently available. Subjects could be asked to guess their treatment assignment, possibly with an option to express the degree of certainty. Assessments of blinding at various points may serve different purposes, i.e. to evaluate comparability between experimental versus control treatments before the trial by the third party; to examine further comparability and credibility of the control treatment and patients' expectation about treatment received in early stage of the trial, and to summarize the overall maintenance of the blinding success at the end of the trial. In this article, we review BIs and how to use these methods along with discussion of other issues in blinding assessment and reporting. We contend the two BIs that were independently developed but carry complementary properties would characterize blinding behaviours in clinical trials qualitatively as well as quantitatively, and may also shed some lights on the interpretation of the study findings. Finally we urge the Item 11b of the CONSORT statement to be revised to require the assessment/reporting of blinding success for all trials that adopt blinding schemes.",
keywords = "Blinding index, Methods, Randomized controlled trials, Standards",
author = "Jafar Kolahi and Heejung Bang and Jongbae Park",
year = "2009",
month = "12",
doi = "10.1111/j.1600-0528.2009.00494.x",
language = "English (US)",
volume = "37",
pages = "477--484",
journal = "Community Dentistry and Oral Epidemiology",
issn = "0301-5661",
publisher = "Blackwell Munksgaard",
number = "6",

}

TY - JOUR

T1 - Towards a proposal for assessment of blinding success in clinical trials

T2 - Up-to-date review

AU - Kolahi, Jafar

AU - Bang, Heejung

AU - Park, Jongbae

PY - 2009/12

Y1 - 2009/12

N2 - The CONSORT statement recommended that investigators should clearly report which key trial persons were blinded to treatment allocation and test for the success of blinding. Clinical researchers, however, more often than not overlook the assessment of the success of blinding. The severe under-reporting on the success of blinding may improve with awareness of existing quantitative methods. The two statistical methods, James' blinding index (BI) and Bang's BI, are currently available. Subjects could be asked to guess their treatment assignment, possibly with an option to express the degree of certainty. Assessments of blinding at various points may serve different purposes, i.e. to evaluate comparability between experimental versus control treatments before the trial by the third party; to examine further comparability and credibility of the control treatment and patients' expectation about treatment received in early stage of the trial, and to summarize the overall maintenance of the blinding success at the end of the trial. In this article, we review BIs and how to use these methods along with discussion of other issues in blinding assessment and reporting. We contend the two BIs that were independently developed but carry complementary properties would characterize blinding behaviours in clinical trials qualitatively as well as quantitatively, and may also shed some lights on the interpretation of the study findings. Finally we urge the Item 11b of the CONSORT statement to be revised to require the assessment/reporting of blinding success for all trials that adopt blinding schemes.

AB - The CONSORT statement recommended that investigators should clearly report which key trial persons were blinded to treatment allocation and test for the success of blinding. Clinical researchers, however, more often than not overlook the assessment of the success of blinding. The severe under-reporting on the success of blinding may improve with awareness of existing quantitative methods. The two statistical methods, James' blinding index (BI) and Bang's BI, are currently available. Subjects could be asked to guess their treatment assignment, possibly with an option to express the degree of certainty. Assessments of blinding at various points may serve different purposes, i.e. to evaluate comparability between experimental versus control treatments before the trial by the third party; to examine further comparability and credibility of the control treatment and patients' expectation about treatment received in early stage of the trial, and to summarize the overall maintenance of the blinding success at the end of the trial. In this article, we review BIs and how to use these methods along with discussion of other issues in blinding assessment and reporting. We contend the two BIs that were independently developed but carry complementary properties would characterize blinding behaviours in clinical trials qualitatively as well as quantitatively, and may also shed some lights on the interpretation of the study findings. Finally we urge the Item 11b of the CONSORT statement to be revised to require the assessment/reporting of blinding success for all trials that adopt blinding schemes.

KW - Blinding index

KW - Methods

KW - Randomized controlled trials

KW - Standards

UR - http://www.scopus.com/inward/record.url?scp=73149122317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73149122317&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0528.2009.00494.x

DO - 10.1111/j.1600-0528.2009.00494.x

M3 - Article

C2 - 19758415

AN - SCOPUS:73149122317

VL - 37

SP - 477

EP - 484

JO - Community Dentistry and Oral Epidemiology

JF - Community Dentistry and Oral Epidemiology

SN - 0301-5661

IS - 6

ER -